Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Regeneron Pharmaceuticals, Inc.
Sort By
Newest First
1 / 1
U.S. Food & Drug Administration
FDA Approval
FDA Approves First Treatment for Ebola Virus
U.S. Food & Drug Administration
PR-M10-20-10
Oct 15, 2020
Regeneron
Staff
Regeneron Adds 400 Jobs in Ireland
Regeneron
PR-M08-20-NI-46
Aug 28, 2020
Regeneron
COVID-19
Regeneron Awarded a $450 Million Contract to Manufacture REGN-COV2
Regeneron
PR-M07-20-NI-008
Jul 07, 2020
Sanofi
COVID-19 Clinical Trial
Sanofi and Regeneron Provide Update on U.S. Phase 2/3 Adaptive-Designed Trial in Hospitalized COVID-19 Patients
Sanofi
PR-M04-20-NI-040
Apr 28, 2020
Regeneron
Priority Review
FDA Accepts for Priority Review Biologics License Application for REGN-EB3 to Treat Ebola
Regeneron
PR-M04-20-NI-025
Apr 17, 2020
Regeneron
Clinical Trials
Regeneron Announces Positive Topline Results from Phase 3 Trial of Evinacumab in Patients With Severe, Inherited form of High Cholesterol
Regeneron
PR-M08-19-NI-049
Aug 19, 2019
Marketing
Visual Marketing Strategy for Libtayo
Emilie Branch
Pharma's Almanac
PAO-M08-19-NI-005
Aug 01, 2019
Bispecific Antibody
Regeneron’s Bispecific Antibody Candidate Shows Positive Results in Early Clinical Studies
Nigel Walker
Nice Insight
PAO-M12-18-NI-007
Dec 05, 2018
Regeneron
Finance
Regeneron to Report Third Quarter 2018 Financial and Operating Results and Host Conference Call and Webcast on November 6, 2018
Regeneron
PR-M10-18-NI-027
Oct 09, 2018
Teva Pharmaceutical Industries
Study Results
Teva and Regeneron Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip
Teva Pharmaceutical Industries
PR-M09-18-NI-051
Sep 18, 2018
Regeneron
Clinical Data
Regeneron and Sanofi Share First Positive Clinical Data for Cemiplimab in Advanced Non-small Cell Lung Cancer at ASCO
Regeneron
PR-M05-18-NI-075
May 21, 2018
Regeneron
Big Data
Regeneron Forms Consortium of Leading Life Sciences Companies to Accelerate Largest Widely-Available 'Big Data' Human Sequencing Resource with UK Biobank
Regeneron
PR-M01-18-NI-020
Jan 10, 2018
FDA Approval
Fresh RA Treatment from Sanofi/Regeneron Approved
Emilie Branch
Pharma's Almanac
PAO-M05-17-NI-024
May 23, 2017
1 / 1
